📈 Syncope Today: Better Diagnosis, Safer Patients, Fewer Falls
Dr. RR Baliga's 'Podkast for the Kurious Doc'. Where Curiosity meets Clarity!
🩺 Why do patients faint—and who is at highest risk? This outstanding NEJM Clinical Practice review provides a practical, evidence-based approach to syncope, emphasizing meticulous history taking, orthostatic blood pressure measurement, ECG, risk stratification, and mechanism-directed management. It also highlights the close relationship between syncope and unexplained falls in older adults, helping clinicians identify patients who require urgent evaluation while avoiding unnecessary hospitalization. 🎙️ #Syncope #Cardiology #EmergencyMedicine #MedicalEducation #NEJM #MedicalPodcasts
info_outline
🍎 The Sweet-Bigger Brain Hypothesis: A New Look at Human Origins
Dr. RR Baliga's 'Podkast for the Kurious Doc'. Where Curiosity meets Clarity!
🍯🧠 Did sugar help build the human brain? This fascinating Science review challenges the long-held belief that meat alone drove human evolution. The authors argue that natural sugars from fruits and honey—and later cooked starch—provided the glucose essential for our expanding brains, reproduction, and survival. The review integrates metabolism, anthropology, genetics, archaeology, and nutrition into a compelling new framework for understanding our evolutionary journey. A thought-provoking read for clinicians, scientists, and anyone interested in human origins. #HumanEvolution...
info_outline
🚑❤️ Vaccines & the Vulnerable Heart: What ACC wants Every Clinician Should Know
Dr. RR Baliga's 'Podkast for the Kurious Doc'. Where Curiosity meets Clarity!
The new 2026 ACC Concise Clinical Guidance highlights why influenza, COVID-19, pneumococcal, RSV, and shingles vaccines should be considered an essential part of cardiovascular prevention. Strong evidence shows reductions in hospitalization, myocardial infarction, heart failure, stroke, and even mortality in selected populations. Prevention extends beyond statins and blood pressure control—it also includes timely immunization. 🎙️ In this episode of Dr RR Baliga’s Podkast for the Kurious Doc, we explore the evidence, practical recommendations, and clinical pearls every cardiovascular...
info_outline
🏥 A Smaller CABG Scar, A Faster Recovery: The MIST Trial
Dr. RR Baliga's 'Podkast for the Kurious Doc'. Where Curiosity meets Clarity!
🫀 Can multivessel CABG be performed through a small thoracotomy without sacrificing safety? The randomized MIST Trial published in The Lancet suggests the answer is yes—for carefully selected patients treated by experienced teams. Patients undergoing minimally invasive CABG experienced faster physical recovery at 1 month, fewer transfusions, and shorter ventilation times, with no apparent safety penalty through 12 months. An important trial that shifts attention toward patient-centered recovery after cardiac surgery. 🎙️ #CardiacSurgery #CABG #MinimallyInvasiveSurgery...
info_outline
💡 Beyond Cholesterol: FNIP1 Redefines Cardiometabolic Risk
Dr. RR Baliga's 'Podkast for the Kurious Doc'. Where Curiosity meets Clarity!
🧬 Can one rare gene reshape our approach to metabolic disease? A remarkable Nature study analyzing more than one million individuals identifies FNIP1 as a key regulator of energy metabolism. Rare loss-of-function variants were associated with healthier lipid profiles, lower liver fat, improved glycaemia, favorable fat distribution, and substantially lower cardiometabolic disease risk. Mechanistic studies in human hepatocytes and mice strengthen the biological story, making FNIP1 an exciting potential therapeutic target. A fascinating example of how human genetics can illuminate tomorrow’s...
info_outline
🫀 The Hidden Mitral Valve Guardian: How Lymphatics Could Transform Marfan Care
Dr. RR Baliga's 'Podkast for the Kurious Doc'. Where Curiosity meets Clarity!
🫀 Can fixing the lymphatic system slow mitral valve degeneration in Marfan syndrome? This elegant JCI study identifies defective lymphangiogenesis and reduced ZFP36-mediated anti-inflammatory signaling as previously unrecognized drivers of myxomatous mitral valve disease. In a mouse model, restoring lymphatic function with VEGF-C156S or activating ZFP36 with fingolimod reduced inflammation and valve thickening, opening an exciting avenue for disease-modifying therapies. A fascinating mechanistic advance with real translational promise. 🎙️ #Cardiology #MarfanSyndrome #ValveDisease...
info_outline
📜 The Pulse Classics: Wang Shuhe, China’s Master Diagnostician
Dr. RR Baliga's 'Podkast for the Kurious Doc'. Where Curiosity meets Clarity!
🩺 Can a physician diagnose disease simply by feeling your pulse? Nearly 1,800 years ago, Wang Shuhe (c. 180–270 CE) transformed pulse-taking into a systematic science through the Maijing (The Pulse Classics). His work shaped Traditional Chinese Medicine for centuries and emphasized that careful observation often reveals what technology cannot. 📖 In this episode of the Great Doctors Series, we explore how one physician elevated diagnosis into an art—and why attentive listening remains one of medicine’s greatest skills. 👋⚕️ #MedicalHistory #TraditionalChineseMedicine...
info_outline
🥩 Less Protein, Longer Life? The Longevity Puzzle
Dr. RR Baliga's 'Podkast for the Kurious Doc'. Where Curiosity meets Clarity!
🥩 Can eating less protein promote healthier aging? This comprehensive review examines how protein restriction—and specifically limiting methionine, isoleucine, and valine—modulates key longevity pathways including FGF21, GCN2, and mTOR. Experimental evidence consistently demonstrates improvements in metabolic health, mitochondrial function, senescence, and lifespan, while early human studies suggest favorable metabolic effects. Although long-term clinical outcome data are still needed, the review challenges conventional assumptions that “more protein is always better.” A fascinating...
info_outline
🌎 LDL-C Without Borders: A Global Call to Action
Dr. RR Baliga's 'Podkast for the Kurious Doc'. Where Curiosity meets Clarity!
🌍 Why is the global LDL-C burden still rising despite decades of progress? The latest JAMA Global Burden of Disease 2023 analysis reveals a striking paradox: age-standardized cardiovascular risk attributable to LDL-C has fallen, yet absolute deaths and disability continue to increase because of population growth and aging. The message is clear—earlier detection, broader access to statins, and stronger preventive strategies remain essential, particularly in middle-income countries. 🫀📉
info_outline
🌱 Feeding Atrial Fibrillation? Gut Microbes, TMAO, and Cardiac Rhythm
Dr. RR Baliga's 'Podkast for the Kurious Doc'. Where Curiosity meets Clarity!
🫀 Can the gut microbiome trigger atrial fibrillation? This elegant JCI study suggests that the microbial metabolite trimethylamine N-oxide (TMAO) is independently associated with AF and mechanistically promotes arrhythmia through muscarinic receptor–mediated autonomic dysfunction. In multiple mouse models, inhibiting microbial TMA production delayed AF onset and attenuated atrial remodeling. While clinical intervention studies are still needed, the work highlights the gut–heart axis as a promising preventive target for AF. A fascinating glimpse into the future of cardiovascular...
info_outlineCoronary CT angiography-guided management of patients
with stable chest pain: 10-year outcomes from the SCOT-
HEART randomised controlled trial in Scotland
Michelle C Williams, Ryan Wereski, Christopher Tuck, Philip D Adamson, Anoop S V Shah, Edwin J R van Beek, Giles Roditi, Colin Berry,Nicholas Boon, Marcus Flather, Steff Lewis, John Norrie, Adam D Timmis, Nicholas L Mills, Marc R Dweck, David E Newby, on behalf of theSCOT-HEART Investigators*
Summary
Background The Scottish Computed Tomography of the Heart (SCOT-HEART) trial demonstrated that management
guided by coronary CT angiography (CCTA) improved the diagnosis, management, and outcome of patients with
stable chest pain. We aimed to assess whether CCTA-guided care results in sustained long-term improvements in
management and outcomes.
Methods SCOT-HEART was an open-label, multicentre, parallel group trial for which patients were recruited from
12 outpatient cardiology chest pain clinics across Scotland. Eligible patients were aged 18–75 years with symptoms of
suspected stable angina due to coronary heart disease. Patients were randomly assigned (1:1) to standard of care plus
CCTA or standard of care alone. In this prespecified 10-year analysis, prescribing data, coronary procedural
interventions, and clinical outcomes were obtained through record linkage from national registries. The primary
outcome was coronary heart disease death or non-fatal myocardial infarction on an intention-to-treat basis. This trial
is registered at ClinicalTrials.gov (NCT01149590) and is complete.
Findings Between Nov 18, 2010, and Sept 24, 2014, 4146 patients were recruited (mean age 57 years [SD 10], 2325 [56·1%] male, 1821 [43·9%] female), with 2073 randomly assigned to standard care and CCTA and 2073 to standard care
alone. After a median of 10·0 years (IQR 9·3–11·0), coronary heart disease death or non-fatal myocardial infarction
was less frequent in the CCTA group compared with the standard care group (137 [6·6%] vs 171 [8·2%]; hazard ratio
[HR] 0·79 [95% CI 0·63–0·99], p=0·044). Rates of all-cause, cardiovascular, and coronary heart disease death, and
non-fatal stroke, were similar between the groups (p>0·05 for all), but non-fatal myocardial infarctions (90 [4·3%] vs
124 [6·0%]; HR 0·72 [0·55–0·94], p=0·017) and major adverse cardiovascular events (172 [8·3%] vs 214 [10·3%];
HR 0·80 [0·65–0·97], p=0·026) were less frequent in the CCTA group. Rates of coronary revascularisation procedures
were similar (315 [15·2%] vs 318 [15·3%]; HR 1·00 [0·86–1·17], p=0·99) but preventive therapy prescribing remained
more frequent in the CCTA group (831 [55·9%] of 1486 vs 728 [49·0%] of 1485 patients with available data; odds ratio
1·17 [95% CI 1·01–1·36], p=0·034).
Interpretation After 10 years, CCTA-guided management of patients with stable chest pain was associated with a
sustained reduction in coronary heart disease death or non-fatal myocardial infarction. Identification of coronary
atherosclerosis by CCTA improves long-term cardiovascular disease prevention in patients with stable chest pain.